In a bid to forestall dementia in terms of early detection and treatment, researchers have developed a sensor which identifies misfolded protein biomarkers (amyloid-beta proteins that cause brain-cells-damaging plaques) in the blood up to 17 years before clinical symptoms of dementia appear.